Reference Susceptibility Testing and Genomic Surveillance of Clostridioides difficile, United States, 2012-17

被引:15
|
作者
Gargis, Amy S. [1 ]
Karlsson, Maria [1 ,2 ]
Paulick, Ashley L. [1 ]
Anderson, Karen F. [1 ]
Adamczyk, Michelle [1 ]
Vlachos, Nicholas [1 ]
Kent, Alyssa G. [1 ]
McAllister, Gillian A. [1 ]
McKay, Susannah L. [1 ]
Halpin, Alison L. [1 ]
Albrecht, Valerie [1 ]
Campbell, Davina [1 ]
Korhonen, Lauren [1 ]
Elkins, Christopher A. [1 ]
Rasheed, J. Kamile [1 ]
Guh, Alice Y. [1 ]
McDonald, L. Clifford [1 ]
Lutgring, Joseph D. [1 ]
机构
[1] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA 30329 USA
[2] Goldbelt C6 LLC, Chesapeake, VA USA
关键词
Clostridioides difficile; antibiotic resistance; vancomycin; metronidazole; agar dilution; ANTIMICROBIAL SUSCEPTIBILITY; RESISTANCE; INFECTION; CARE; EMERGENCE; EPIDEMIC;
D O I
10.1093/cid/ciac817
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Reference susceptibility testing revealed that elevated minimum inhibitory concentrations (MICs) to vancomycin and metronidazole were rare among US Clostridioides difficile isolates. Ribotype 027 was associated with increased MICs to several antibiotics including fluoroquinolones and clindamycin. Background Antimicrobial susceptibility testing (AST) is not routinely performed for Clostridioides difficile and data evaluating minimum inhibitory concentrations (MICs) are limited. We performed AST and whole genome sequencing (WGS) for 593 C. difficile isolates collected between 2012 and 2017 through the Centers for Disease Control and Prevention's Emerging Infections Program. Methods MICs to 6 antimicrobial agents (ceftriaxone, clindamycin, meropenem, metronidazole, moxifloxacin, and vancomycin) were determined using the reference agar dilution method according to Clinical and Laboratory Standards Institute guidelines. Whole genome sequencing was performed on all isolates to detect the presence of genes or mutations previously associated with resistance. Results Among all isolates, 98.5% displayed a vancomycin MIC <= 2 mu g/mL and 97.3% displayed a metronidazole MIC <= 2 mu g/mL. Ribotype 027 (RT027) isolates displayed higher vancomycin MICs (MIC50: 2 mu g/mL; MIC90: 2 mu g/mL) than non-RT027 isolates (MIC50: 0.5 mu g/mL; MIC90: 1 mu g/mL) (P < .01). No vanA/B genes were detected. RT027 isolates also showed higher MICs to clindamycin and moxifloxacin and were more likely to harbor associated resistance genes or mutations. Conclusions Elevated MICs to antibiotics used for treatment of C. difficile infection were rare, and there was no increase in MICs over time. The lack of vanA/B genes or mutations consistently associated with elevated vancomycin MICs suggests there are multifactorial mechanisms of resistance. Ongoing surveillance of C. difficile using reference AST and WGS to monitor MIC trends and the presence of antibiotic resistance mechanisms is essential.
引用
收藏
页码:890 / 896
页数:7
相关论文
共 50 条
  • [31] Budget Impact Analysis of Fidaxomicin Versus Vancomycin for the Treatment of Clostridioides difficile Infection in the United States
    Jiang, Yiling
    Sarpong, Eric M.
    Sears, Pamela
    Obi, Engels N.
    INFECTIOUS DISEASES AND THERAPY, 2022, 11 (01) : 111 - 126
  • [32] Fecal Microbiota Transplantation and Clostridioides difficile Infection Among Privately Insured Patients in the United States
    El Halabi, Jessica
    Palmer, Natha P.
    Fox, Kathe
    Kohane, Isaac
    Farhat, Maha R.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S76 - S77
  • [33] Fecal microbiota transplantation and Clostridioides difficile infection among privately insured patients in the United States
    El Halabi, Jessica
    Palmer, Nathan
    Fox, Kathe
    Kohane, Isaac
    Farhat, Maha R.
    JOURNAL OF GASTROENTEROLOGY, 2022, 57 (01) : 10 - 18
  • [34] Fecal microbiota transplantation and Clostridioides difficile infection among privately insured patients in the United States
    Jessica El Halabi
    Nathan Palmer
    Kathe Fox
    Isaac Kohane
    Maha R. Farhat
    Journal of Gastroenterology, 2022, 57 : 10 - 18
  • [35] STD CASE SURVEILLANCE DATA QUALITY UNITED STATES, 2012
    Nelson, Robert
    Torrone, Elizabeth
    Dooley-Edwards, Sheila
    Caron, Julie
    Harvey, Alesia
    Kidd, Sarah
    Su, John R.
    Carey, Delicia
    SEXUALLY TRANSMITTED DISEASES, 2014, 41 : S128 - S129
  • [36] Active Transportation Surveillance - United States, 1999-2012
    Whitfield, Geoffrey P.
    Paul, Prabasaj
    Wendel, Arthur M.
    MMWR SURVEILLANCE SUMMARIES, 2015, 64 (07): : 1 - 17
  • [37] A Reevaluation of Clostridioides difficile Impact on Hospitalized IBD Patients in the United States: Disproving the Notion of Worst Outcome
    Zhou, Sheng
    Abdu, Manasik
    Krugliak, Netanel
    Shah, Samir A.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1066 - S1067
  • [38] Evaluation of disk diffusion method for testing the rifampicin, erythromycin, and tetracycline susceptibility of Clostridioides (prev. Clostridium) difficile
    Carvalho, Gabriela Muniz
    Silva, Brendhal Almeida
    Xavier, Rafael Gariglio Clark
    Zanon, Isabela Padua
    Vilela, Eduardo Garcia
    Nicolino, Rafael Romero
    Tavares, Guilherme Campos
    Silva, Rodrigo Otavio Silveira
    ANAEROBE, 2023, 80
  • [39] Antimicrobial susceptibility of Clostridioides difficile isolated from diarrhoeal stool specimens of Canadian patients: summary of results from the Canadian Clostridioides difficile (CAN-DIFF) surveillance study from 2013 to 2017
    Karlowsky, James A.
    Adam, Heather J.
    Baxter, Melanie R.
    Dutka, Christopher W.
    Nichol, Kim A.
    Laing, Nancy M.
    Golding, George R.
    Zhanel, George G.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (07) : 1824 - 1832
  • [40] Coordinating SARS-CoV-2 genomic surveillance in the United States
    Nelson, Martha, I
    Thielen, Peter
    VIRUS EVOLUTION, 2021, 7 (02)